229 related articles for article (PubMed ID: 28333259)
1. Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
Bretagne S; Renaudat C; Desnos-Ollivier M; Sitbon K; Lortholary O; Dromer F;
J Antimicrob Chemother; 2017 Jun; 72(6):1784-1793. PubMed ID: 28333259
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
[TBL] [Abstract][Full Text] [Related]
6. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
[TBL] [Abstract][Full Text] [Related]
7. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
8. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
9. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
10. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility.
Arendrup MC; Fuursted K; Gahrn-Hansen B; Schønheyder HC; Knudsen JD; Jensen IM; Bruun B; Christensen JJ; Johansen HK
Clin Microbiol Infect; 2008 May; 14(5):487-94. PubMed ID: 18294241
[TBL] [Abstract][Full Text] [Related]
11. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
[TBL] [Abstract][Full Text] [Related]
12. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
Krcmery V; Huttova M; Mateicka F; Laho L; Jurga L; Ondrusova A; Tarekova Z; Kralinsky K; Hanzen J; Liskova A; Mrazova M; Sabo A; Pisarcikova M; Kovacicova G; Chovancova D; Szovenyiova Z
J Antimicrob Chemother; 2001 Oct; 48(4):521-5. PubMed ID: 11581231
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].
Pemán J; Cantón E; Miñana JJ; Florez JA; Echeverria J; Ortega DN; Alarcón JM; Fontanals D; Sard BG; Moreno BB; Torroba L; Ayats J; Pérez MÁ; Fernández MA; Reus FS; Natal IF; García GR; Ezpeleta G; Martín-Mazuelos E; Iglesias I; Rezusta A; de Ocariz IR; Nieto AG;
Rev Iberoam Micol; 2011; 28(2):91-9. PubMed ID: 21376831
[TBL] [Abstract][Full Text] [Related]
15. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
Córdoba S; Vivot W; Bosco-Borgeat ME; Taverna C; Szusz W; Murisengo O; Isla G; Davel G;
Rev Argent Microbiol; 2011; 43(3):176-85. PubMed ID: 22430989
[TBL] [Abstract][Full Text] [Related]
16. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
[TBL] [Abstract][Full Text] [Related]
17. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
[TBL] [Abstract][Full Text] [Related]
18. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
19. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group.
Krcméry V; Kovacicová G
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):7-11. PubMed ID: 10744362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]